Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Biotechs With Major Catalysts Incoming
Motley Fool
Wednesday, March 19, 2014 - 11:22am
tags:
dalbavancin, Durata Therapeutics, MannKind, Afrezza, Cologuard, EXACT Sciences
Impax, Par Pharmaceutical stayed from selling generic version of Avanir drug
The Fly on the Wall
Wednesday, March 19, 2014 - 11:05am
tags:
Impax Laboratories, Avanir, generics, Par Pharmaceutical, Nuedexta
Are Biotech Stocks Located in Ireland Top Buyout Candidates?
Wall St 24/7
Wednesday, March 19, 2014 - 10:24am
tags:
Vidara, Shire, Perrigo, M&A, Jazz Pharmaceuticals, Ireland, Endo Health Solutions, biotech, Amarin, Alkermes
Horizon Pharma to buy privately held Vidara for about $660 mln
Yahoo/Reuters
Wednesday, March 19, 2014 - 9:57am
tags:
Horizon Pharma, Vidara, M&A
In Brief: Why Apple's Healthbook Is So Important
Forbes
Wednesday, March 19, 2014 - 9:55am
tags:
mobile medical apps, Healthbook, devices, Apple
GeoVax: Moving forward with both preventive and therapeutic HIV vaccine programs
Yahoo/Zacks.com
Wednesday, March 19, 2014 - 9:53am
tags:
GeoVax, vaccines, HIV
Celgene reiterates commitment to improving pancreatic cancer care in Europe
Yahoo/Fly on the Wall
Wednesday, March 19, 2014 - 9:52am
tags:
Celgene, pancreatic cancer, Europe
Johnson & Johnson's Sale Of K-Y Brand To Reckitt Benckiser Confirms Focus on Pharma
Forbes
Wednesday, March 19, 2014 - 9:51am
tags:
JNJ, Reckitt Benckiser, K-Y
Forest Laboratories' Recovery
Yahoo/Guru Focus
Tuesday, March 18, 2014 - 11:20pm
tags:
Forest Labs
Roche-backed study finds Tamiflu saved lives in flu pandemic
Reuters
Tuesday, March 18, 2014 - 11:19pm
tags:
Roche, Flu, Tamiflu
The Lesson of Allergan
TheStreet.com
Tuesday, March 18, 2014 - 11:18pm
tags:
Allergan, DARPin, macular degeneration
Biogen to be added to S&P100
Yahoo/Zacks.com
Tuesday, March 18, 2014 - 1:38pm
tags:
Biogen Idec
IPO Could Be Too Little, Too Early For Akebia Therapeutics
Seeking Alpha
Tuesday, March 18, 2014 - 1:37pm
tags:
IPOs, Akebia Therapeutics, anemia
Galena Discloses SEC Investigation Focused on Stock-Touting Campaign
TheStreet.com
Tuesday, March 18, 2014 - 12:26pm
tags:
Galena Biopharma, SEC
Novo Nordisk taps bankers for potential IT unit spinoff
Fierce Pharma
Tuesday, March 18, 2014 - 12:16pm
tags:
Novo Nordisk, spinoffs
FDA New Molecular Entities - Finding Them Ahead Of Approval But Also Ahead Of The Herd
Seeking Alpha
Tuesday, March 18, 2014 - 12:15pm
tags:
drug approvals, FDA, new molecular entity
MLV Sees A Good Chance Of FDA Approval For MannKind's Afrezza And 60% Upside
Seeking Alpha
Tuesday, March 18, 2014 - 12:14pm
tags:
FDA, MannKind, Afrezza, diabetes
Eager biotechs eye $133M in IPOs as a frenzied quarter closes
Fierce Biotech
Tuesday, March 18, 2014 - 11:10am
tags:
IPOs, biotech, Aldeyra Therapeutics, GlobeImmune, Agile Therapeutics
Pfizer's impressive Prevnar data isn't enough to win billions in adult sales
Fierce Pharma Marketing
Tuesday, March 18, 2014 - 10:51am
tags:
Pfizer, vaccines, Prevnar 13
FDA puts highest-risk label on McKesson's anesthesia system recall
Mass Device
Tuesday, March 18, 2014 - 10:50am
tags:
FDA, anesthesia, recalls, McKesson, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.